Recent Press Releases

Immunovaccine and NCIC Clinical Trials Group To Collaborate on Phase II Study of DPX-Survivac

Immunovaccine and NCIC Clinical Trials Group To Collaborate on Phase II Study of DPX-Survivac NCIC CTG to Sponsor Randomized Trial With Approximately 250 Ovarian Cancer Patients HALIFAX, NOVA SCOTIA,...

Sabin Vaccine Institute Begins New Vaccine Discovery Initiative

Sabin Vaccine Institute Begins New Vaccine Discovery Initiative Program intends to develop and test a vaccine against all four major parasitic worm infections WASHINGTON, DC—July 15,...

Medicago announces agreement to be acquired by Mitsubishi Tanabe Pharma in a transaction valued at $357M

Medicago announces agreement to be acquired by Mitsubishi Tanabe Pharma in a transaction valued at $357M 07/12/2013 QUÉBEC CITY, July 12, 2013 /CNW/ - Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a...

ARTES Biotechnology and Bio Farma Announce Collaboration in Vaccine Development

ARTES Biotechnology and Bio Farma Announce Collaboration in Vaccine Development Langenfeld, Germany / Jakarta, Indonesia, July 15, 2013 / B3C newswire / - ARTES and Bio Farma announced today to join...

Inovio Pharmaceuticals' Universal H7N9 DNA Vaccine Protects 100% of Vaccinated Animals in Challenge Study

Inovio Pharmaceuticals' Universal H7N9 DNA Vaccine Protects 100% of Vaccinated Animals in Challenge Study For the first time a vaccine shields animals from sickness and death against the newly...

Novavax Initiates First Phase 1 Clinical Trial of Its A(H7N9) Influenza Vaccine Candidate

Novavax Initiates First Phase 1 Clinical Trial of Its A(H7N9) Influenza Vaccine Candidate ROCKVILLE, Md., July 8, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that enrollment...

Novartis and Biological E agree to deliver affordable vaccines for typhoid and paratyphoid A fevers to developing world

License agreement advances a Novartis goal to deliver accessible and affordable vaccines that address unmet medical need in endemic regions More than 21 million cases of typhoid fever and five...

New Barcodes on Vaccines Enhance Safety of the US Immunization System, Save Millions

Newswise — RESEARCH TRIANGLE PARK, N.C. – Using two-dimensional barcodes on vaccine product labels would enhance the safety of the U.S. immunization system and save more than $300 million...

WHO sends mission to Israel following detection of wild poliovirus in sewage

As requested by Israeli health authorities, a team of international poliomyelitis (polio) experts, coordinated by WHO, completed a five-day mission to Israel on 26 June 2013. The team assessed the...

Sabin Vaccine Institute launches International Association of Immunization Managers

Sabin Vaccine Institute launches International Association of Immunization Managers New association seeks to support immunization managers to achieve vaccination goals WASHINGTON, D.C.—June 24,...

Inovio's Universal H7N9 DNA Vaccine Generates First Protective Antibody Responses Against Virulent H7N9 Virus in 100% of Vaccinated Animals

Inovio's Universal H7N9 DNA Vaccine Generates First Protective Antibody Responses Against Virulent H7N9 Virus in 100% of Vaccinated Animals Universal H7N9 vaccine generates protective HAI...

Experimental vaccine shows promise against TB meningitis

Experimental vaccine shows promise against TB meningitis 11-Jun-2013 Study in animals lays groundwork for new prevention strategies in brain TB A team of Johns Hopkins researchers working with...

Argos Therapeutics Announces US and Global Expansion for Ongoing Pivotal Phase 3 ADAPT Study for Personalized Immunotherapy

Argos Therapeutics Announces US and Global Expansion for Ongoing Pivotal Phase 3 ADAPT Study for Personalized Immunotherapy Studies Presented During 2013 ASCO Meeting Further Validate ADAPT Study...

Medicago is First in the World to Report Positive Interim Results for its H7N9 Pre-Clinical Trial

Medicago is First in the World to Report Positive Interim Results for its H7N9 Pre-Clinical Trial 06/06/2013 - The H7 VLP vaccine candidate induces an antibody response after a single dose in mice-...

Novavax Produces MERS-CoV Vaccine Candidate

Novavax Produces MERS-CoV Vaccine Candidate ROCKVILLE, Md., June 6, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today that it had successfully produced a vaccine candidate...

Medicago is First in the World to Report Positive Interim Results for its H7N9 Pre-Clinical Trial

Medicago is First in the World to Report Positive Interim Results for its H7N9 Pre-Clinical Trial - The H7 VLP vaccine candidate induces an antibody response after a single dose in mice- Quebec City,...

FDA Lifts Clinical Hold On PharmAthene's SparVax® Anthrax Vaccine Program

FDA Lifts Clinical Hold On PharmAthene's SparVax® Anthrax Vaccine Program ANNAPOLIS, Md., May 30, 2013 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing...

Immunovaccine Shows Pronounced and Persistent T Cell Immune Responses in DPX-Survivac Cancer Vaccine Study Presented at American Society of Clinical Oncology (ASCO) Meeting

Immunovaccine Shows Pronounced and Persistent T Cell Immune Responses in DPX-Survivac Cancer Vaccine Study Presented at American Society of Clinical Oncology (ASCO) Meeting Immune responses...

Celerion Expands Belfast Facility with Containment Room to Enable Live Biologics and Vaccine Studies

Celerion Expands Belfast Facility with Containment Room to Enable Live Biologics and Vaccine Studies (Lincoln, NE; June 5, 2013) – Celerion, announces the addition of a Containment Room at the...

Sinovac Files New Drug Application for EV71 Vaccine and Receives Filing Acceptance from Beijing Drug Administration

Sinovac Files New Drug Application for EV71 Vaccine and Receives Filing Acceptance from Beijing Drug Administration BEIJING, May 30, 2013 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a...